Text/HTML
Text/HTML
If you are a registered user please log in to see more postings.
 

The AAO Weblog covers accounting issues and current events as they relate the practice of investment analysis.

 
 
Apr 18

Written by: Jack Ciesielski
4/18/2005 8:21 AM 

Now that the implementation date for Statement 123(Revised) has been delayed for calendar year firms, there's time for HR 913, the "Broad-Based Stock Option Plan Transparency Act" - a fantastic piece of double-speak - to gather steam in Congress.

The bill is recycled version of the one introduced last year by Rep. David Dreier and Rep. Anna Eshoo of California; it intends to accomplish the same thing, namely to stop the FASB in its tracks from ever getting Statement 123(Revised) into financial statements. How? Look at some of the requirements of the bill:

"[It] directs the SEC to examine and report to specified congressional committees on the effectiveness of the enhanced disclosures required by this Act in increasing transparency to current and potential investors.

[It] prohibits the Commission, between enactment of this Act and submission of such report, from recognizing as generally accepted accounting principles any new accounting standards regarding the treatment of stock options.

[It] directs the Secretary of Commerce to analyze and report to specified congressional committees on broad-based employee stock option plans, particularly in the high technology and any other high growth industries."

In short, it's death by delay. At least some of those tech companies that the Secretary of Commerce will be studying should have been reporting under Statement 123(Revised) soon, given that the SEC's delay of Statement 123 (Revised) didn't affect them.

There are now 40 co-sponsors of the bill; they're listed on this page. If you're represented by any of them, you should drop them a line and offer your discouragement.

Tags:
 

Unexplored Obligations: Other Postretirement Benefits

Defined benefit pension plans take center stage in the pantheon of investors’ fears when it comes to worrying about liquidity effects or earnings distortions. Yet they rarely consider the cash demands and earnings distortions resulting from other postretirement benefit plans.

Since they’ve been required to measure - and display - a figure expressing the value of the promises made for providing employee health care benefits, managers have dealt vigorously with the obligations. Their growth has been held in check while pension obligations have grown ever higher. Yet even as they’ve become more controlled, other postretirement benefit plans are worth investor attention. As the benefit plans become less fearsome, the accounting principles involved have helped an increasing number of companies recognize phantom earnings - negative benefit costs - even while they’re putting cash into benefit payments under these plans. It’s better to be alert to such a trend early: firms may not always bring it to the attention of investors.

A recent edition of The Analyst’s Accounting Observer looks at the problematic reporting, with an eye focused on the "phantom income" results shown by 42 companies having negative OPEB costs. While the report is available only to paid subscribers, a condensed version is available for free upon request. To receive it, send an e-mail to Brenda Rappold at brappold@accountingobserver.com, with “OPEB Costs” in the subject line.


For information about subscribing to The Analyst’s Accounting Observer, click here.